CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
CHOC’s pediatric colorectal program makes a significant impact on children with treatments and tools for correcting colorectal issues.
A first-of-its-kind study by CHOC found that awareness and safety precautions are vital to prevent severe injuries from mechanic bull riding.
CHOC doctors discover the possible efficacy of treating PCS with the GI device IB-Stim. A clinical trial is underway.
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.